Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by AQR Capital Management LLC

AQR Capital Management LLC lessened its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 41.8% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,548 shares of the biotechnology company’s stock after selling 3,270 shares during the quarter. AQR Capital Management LLC’s holdings in Axon Enterprise were worth $1,338,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. raised its position in shares of Axon Enterprise by 2.7% during the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock valued at $2,547,878,000 after acquiring an additional 212,401 shares in the last quarter. Motley Fool Asset Management LLC grew its position in shares of Axon Enterprise by 238.7% during the 1st quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company’s stock valued at $153,981,000 after buying an additional 346,838 shares during the last quarter. 1832 Asset Management L.P. lifted its holdings in Axon Enterprise by 44.0% in the second quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company’s stock worth $110,546,000 after acquiring an additional 114,800 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its stake in Axon Enterprise by 13.9% in the second quarter. Allspring Global Investments Holdings LLC now owns 368,732 shares of the biotechnology company’s stock valued at $108,496,000 after acquiring an additional 45,049 shares during the period. Finally, Goldman Sachs Group Inc. grew its holdings in shares of Axon Enterprise by 110.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 276,011 shares of the biotechnology company’s stock valued at $71,302,000 after purchasing an additional 144,568 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Trading Down 0.8 %

Shares of AXON opened at $428.76 on Friday. Axon Enterprise, Inc. has a 52-week low of $199.29 and a 52-week high of $433.48. The company has a market cap of $32.40 billion, a price-to-earnings ratio of 125.37, a PEG ratio of 11.30 and a beta of 0.94. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88. The stock has a fifty day moving average price of $375.57 and a two-hundred day moving average price of $326.60.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The business had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. During the same quarter in the prior year, the company posted $0.80 earnings per share. The firm’s revenue was up 34.5% on a year-over-year basis. Analysts predict that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on AXON. Bank of America initiated coverage on Axon Enterprise in a research report on Wednesday, July 17th. They set a “buy” rating and a $380.00 price objective for the company. Craig Hallum lifted their price target on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research report on Wednesday, August 7th. Robert W. Baird lifted their price target on shares of Axon Enterprise from $360.00 to $400.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 10th. Northland Securities raised their target price on Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a research report on Thursday, August 8th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $400.00 target price on shares of Axon Enterprise in a research report on Wednesday, August 7th. Two analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $365.38.

Insider Activity

In other Axon Enterprise news, President Joshua Isner sold 25,811 shares of the stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the completion of the transaction, the president now owns 228,166 shares in the company, valued at approximately $82,103,253.44. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Jeri Williams sold 110 shares of the firm’s stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $400.00, for a total transaction of $44,000.00. Following the completion of the sale, the director now owns 1,934 shares in the company, valued at approximately $773,600. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, President Joshua Isner sold 25,811 shares of the business’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total value of $9,287,830.24. Following the completion of the sale, the president now owns 228,166 shares of the company’s stock, valued at $82,103,253.44. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 370,172 shares of company stock worth $136,562,182 in the last 90 days. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.